Ock S et al
Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery
GLP-1 drugs like Ozempic, Wegovy reduce Alzheimers risk for those with diabetes Videos GLP-1 drugs like Ozempic, Wegovy reduce Alzheimers risk for those with diabetes01:54 | April 7, 2025 Doctors show CT scans of serious injuries as a result of e-scooter use02:13 | 10 hours ago Rate of e-scooter injuries increasing in ERs, doctors say02:05 | August 1, 2026 Health Matters: West Nile risk increases in Hamilton, Ont.02:04 | July 31, 2026 Congo struggles to contain fastest-ever Ebola outbreak, as death toll passes 1,50001:47 | July 30, 2026 Health Matters: Health Canada grants injunction against unauthorized peptide producer02:13 | July 30, 2026 Dr
Retatrutide is a triple agonist (GIP/GLP-1/glucagon) currently in clinical trials that has shown weight loss exceeding 24% of body weight
The CBO has estimated that if every eligible beneficiary enrolled in the Bridge initiative annual taxpayer spending on the program could exceed $30 billion
Usually theyll evaluate the product on safety and efficacy first
